From: Synthesis of some novel 4-arylidene pyrazoles as potential antimicrobial agents
Compound a | Diameter of zone of inhibition in mm (MIC) b | |
---|---|---|
 | Candida albicans | Saccharomyces cerevisiae |
4a | 12 ± 0.43 (400) | 28 ± 0.15 (0.04) |
4b | 12 ± 0.56 (400) | 16 ± 0.38 (40) |
4c | 12 ± 0.54 (400) | 16 ± 0.40 (40) |
4d | 14 ± 0.14 (400) | 20 ± 0.45 (4.0) |
4e | 12 ± 0.45 (400) | 18 ± 0.16 (40) |
4f | 12 ± 0.32 (400) | 16 ± 0.27 (40) |
4g | 16 ± 0.27 (40) | 18 ± 0.48 (40) |
5a | 12 ± 0.32 (400) | 16 ± 0.00 (40) |
5b | 12 ± 0.33 (400) | 28 ± 0.28 (0.04) |
5c | - | 16 ± 0.00 (40) |
5d | 12 ± 0.23 (400) | 18 ± 0.18 (40) |
5e | 13 ± 0.37 (400) | 22 ± 0.44 (4.0) |
5f | - | 16 ± 0.30 (40) |
5g | 12 ± 0.43 (400) | 20 ± 0.10 (4.0) |
Fluconazole | 16 ± 0.45 (40) | 24 ± 0.50 (40) |